Privacy protected and anonymized by ShouldEye. No AI training. Learn more
AI Trust Score, Reviews & Company Verification
Is this your company? Claim the Alcon Inc. profile to verify ownership and manage company-provided details.
Independent company assessment
8.7/10B · Solid
33 indexed evidence signals reviewed
AI Comparison
🟡Mixed Consensus70% Confidence
Based on 5 polled AI models
GeminiGoogle DeepMindMixed75%Confidence
GrokxAIMixed72%Confidence
DeepSeekDeepSeekMixed65%ConfidenceGLMZ.ai
Safe72%Confidence
Key stats
- Sector
- Medical Device Companies
- Headquarters
- US
- Domain
- alcon.com
- Domain history
- Not available
- Risk tier
- Moderate
- Assessed
- Aug 27, 2026
Alcon Inc. hasn't claimed this profile yet
ShouldEye AI builds this page from public sources. Nothing here is approved by Alcon Inc..
- Reply to reviews
- Publish your brand message
- Earn the trust seal
Claiming gives you a voice, not control of the trust score.
Free for verified company teams
Alcon Inc. is a Swiss‑American pharmaceutical and medical device company that develops and manufactures eye care products, including surgical devices and contact lenses, with a mission to help people see better.
- Headquarters
- US
Full intelligence report for Alcon Inc.
Alcon demonstrates strong operational reliability in regulatory compliance and customer service, reflecting well-managed verification processes and responsive consumer support. Its comparatively weaker reputation indicates that public perception lags slightly behind these internal strengths, suggesting some disconnect between operational reality and external sentiment. As a verified provider, Alcon maintains a fundamentally solid trust profile, though consumers should weigh its robust backend practices against the more mixed signals coming from broader marketplace reputation.
- Implemented robust global integrity and compliance programs following regulatory actions
- Avoided appointment of an independent compliance monitor in the FCPA settlement
- Transparent public disclosures of payments to healthcare parties
- Major FCPA enforcement action with a multi‑million‑dollar settlement and required compliance program enhancements
- Historical compliance program failures leading to OFAC sanctions violations
- Ongoing regulatory investigation by SIX Exchange Regulation AG
Connect with Alcon Inc.
Find us across the web
- TikTok
- YouTube
- X
- Threads
- Snapchat
- Discord
No social profiles found yet.
Discovering leadership team…